Skip to main content
Equibles

Josh Disbrow

CEO

Aytu Biopharma, Inc (AYTU)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Josh Disbrow

Josh Disbrow is recorded as CEO at Aytu Biopharma, Inc (AYTU). Josh Disbrow has spoken on 16 earnings calls across 1 company, most recently for Aytu Biopharma, Inc on September 22, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Aytu Biopharma, Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 4 earlier activities